New Device for More Protection in Carotid Artery Stenting

This new “Paladin” system for post-dilation during carotid artery stenting was safe and may effectively reduce the number of particles that reach the brain, with a subsequent decreased risk for peri-procedural stroke.

Nuevo dispositivo para tener mayor protección en la angioplastia carotídeaThis study evaluated the safety and efficacy of the Paladin System, a novel post-dilation balloon with an integrated distal protection filter designed to increase safety during one of the most critical procedural moments: post-stent dilation.

 

While the risk of major adverse events during stenting is equivalent to that during endarterectomy, the risk of minor stroke, much of which occurs during post-stent dilation, remains higher with carotid artery stenting.

 

This study enrolled a total of 106 patients in 5 centers in Germany; the primary endpoint was all-cause death, acute myocardial infarction, and stroke within 30 days from the procedure.


Read also: Effect of More Expedited Carotid Intervention on Recurrent Events.


Among cohort patients, 30 subjects were assessed through diffusion-weighted magnetic resonance imaging before and after the procedure, in search for new lesions.

 

There was a retrospective analysis comparing outcomes with historical controls.

 

Procedural and device success rates were 100%. The combined event (death, infarction, and stroke) rates at discharge and at 30 days were 0% and 1%, respectively.


Read also: Safety of Early Carotid Artery Stenting in Symptomatic Patients.


The single adverse event was a stroke at day 12 that is believed to be unrelated to the device or the procedure.

 

Diffusion-weighted magnetic resonance imaging found new lesions in 36.7% of patients, and 30% of such lesions were ipsilateral.

 

Debris was present in all filters, and 90% of these particles were <100 μm.

 

Conclusion

The Paladin System for post-stent dilation with greater protection during carotid artery stenting is effective and may reduce the number of embolic particles, with a subsequent reduction in peri-procedural stroke.

 

Original title: Double Filtration During Carotid Artery Stenting Using a Novel Post-Dilation Balloon with Integrated Embolic Protection.

Reference: Ralf Langhoff et al. J Am Coll Cardiol Intv 2019;12:395-403.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...